Crossref journal-article
Elsevier BV
Cell Chemical Biology (78)
Bibliography

Telling, N. D., Everett, J., Collingwood, J. F., Dobson, J., van der Laan, G., Gallagher, J. J., Wang, J., & Hitchcock, A. P. (2017). Iron Biochemistry is Correlated with Amyloid Plaque Morphology in an Established Mouse Model of Alzheimer’s Disease. Cell Chemical Biology, 24(10), 1205-1215.e3.

Authors 8
  1. Neil D. Telling (first)
  2. James Everett (additional)
  3. Joanna F. Collingwood (additional)
  4. Jon Dobson (additional)
  5. Gerrit van der Laan (additional)
  6. Joseph J. Gallagher (additional)
  7. Jian Wang (additional)
  8. Adam P. Hitchcock (additional)
References 49 Referenced 143
  1. 10.1371/journal.pone.0081093 / PLoS One / In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease by Acosta-Cabronero (2013)
  2. 10.1006/abbi.2000.2023 / Arch. Biochem. Biophys. / Arsenic species that cause release of iron from ferritin and generation of activated oxygen by Ahmad (2000)
  3. 10.1016/j.neuroimage.2011.08.019 / Neuroimage / Relaxation properties of human hippocampus in Alzheimer's disease using high field MRI microscopy by Antharam (2012)
  4. 10.1111/j.1472-4669.2012.00329.x / Geobiology / Characterisation of the dissimilatory reduction of Fe(III)-oxyhydroxide at the microbe – mineral interface: the application of STXM–XMCD by Coker (2012)
  5. 10.3233/JAD-2008-14211 / J. Alzheimers Dis. / Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer’s plaque core material by Collingwood (2008)
  6. 10.3233/JAD-2005-7401 / J. Alzheimers Dis. / In situ characterization and mapping of iron compounds in Alzheimer’s disease tissue by Collingwood (2005)
  7. {'key': '10.1016/j.chembiol.2017.07.014_bib7', 'series-title': 'Iron Oxides: From Nature to Applications', 'first-page': '143', 'article-title': 'Iron oxides in the human brain', 'author': 'Collingwood', 'year': '2016'} / Iron Oxides: From Nature to Applications / Iron oxides in the human brain by Collingwood (2016)
  8. 10.1002/cphc.200901023 / ChemPhysChem / In-situ scanning transmission X-ray microscopy of catalytic solids and related nanomaterials by de Groot (2010)
  9. 10.1089/ars.2013.5593 / Antioxid. Redox Signal. / Targeting chelatable iron as a therapeutic modality in Parkinson’s disease by Devos (2014)
  10. 10.1016/S0306-4522(01)00169-5 / Neuroscience / The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease by Dickson (2001)
  11. 10.1016/S0014-5793(01)02386-9 / FEBS Lett. / Nanoscale biogenic iron oxides in neurodegenerative disease by Dobson (2001)
  12. 10.1016/0361-9230(95)02132-9 / Brain Res. Bull. / Magnetic properties of human hippocampal tissue: evaluation of artefact and contamination sources by Dobson (1996)
  13. 10.1002/mrm.21266 / Magn. Reson. Med. / Transverse relaxation time reflects brain amyloidosis in young APP/PS1 transgenic mice by El Tannir El Tayara (2007)
  14. 10.1021/ic402406g / Inorg. Chem. / Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer’s disease peptide β-amyloid by Everett (2014)
  15. 10.1098/rsif.2014.0165 / J. R. Soc. Interface / Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer’s disease peptide β-amyloid (1-42) by Everett (2014)
  16. 10.1016/j.tibs.2011.02.002 / Trends Biochem. Sci. / Recent progress in understanding Alzheimer's beta-amyloid structures by Fandrich (2011)
  17. 10.3233/JAD-2011-110614 / J. Alzheimers Dis. / Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress by Gallagher (2012)
  18. 10.1038/25334 / Nature / Ratios of ferrous to ferric iron from nanometre-sized areas in minerals by Garvie (1998)
  19. 10.1016/j.neurobiolaging.2012.05.009 / Neurobiol. Aging / Intranasal deferoamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease by Guo (2013)
  20. 10.3233/JAD-2004-6310 / J. Alzheimers Dis. / Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Aβ42 in a manner which may have consequences for metal chelation therapy in Alzheimer’s disease by House (2004)
  21. 10.1021/bi990438f / Biochemistry / The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction by Huang (1999)
  22. 10.1007/s00775-004-0602-8 / J. Biol. Inorg. Chem. / Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's A beta peptides by Huang (2004)
  23. 10.1021/es801642z / Environ. Sci. Technol. / Mapping the speciation of iron in Pseudomonas aeruginosa by Hunter (2008)
  24. 10.1016/j.freeradbiomed.2005.09.013 / Free Radic. Biol. Med. / Redox cycling of iron by A-beta42 by Khan (2006)
  25. 10.1073/pnas.89.16.7683 / Proc. Natl. Acad. Sci. USA / Magnetite biomineralization in the human brain by Kirschvink (1992)
  26. 10.3390/ma3073911 / Materials / Characterization of biomaterials by soft X-ray spectromicroscopy by Leung (2010)
  27. 10.1021/ma802130n / Macromolecules / A new approach to studying microcapsule wall growth mechanisms by Li (2009)
  28. 10.1074/jbc.M110.158980 / J. Biol. Chem. / Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation by Liu (2011)
  29. 10.1111/j.1471-4159.1993.tb03639.x / J. Neurochem. / Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide by Mantyh (1993)
  30. 10.1002/jmri.21731 / J. Magn. Reson. Imaging / Magnetic resonance imaging and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice by Meadowcroft (2009)
  31. 10.1002/nbm.3247 / NMR Biomed. / The effect of iron in MRI and transverse relaxation of amyloid-beta plaques in Alzheimer's disease by Meadowcroft (2014)
  32. 10.1016/j.neuroimage.2006.11.053 / Neuroimage / Internet-enabled high-resolution brain mapping and virtual microscopy by Mikula (2007)
  33. 10.1038/srep24873 / Sci. Rep. / High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's disease by Plascencia-Villa (2016)
  34. 10.1016/j.jsb.2004.03.001 / J. Struct. Biol. / Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin by Quintana (2004)
  35. 10.1103/PhysRevB.64.214422 / Phys. Rev. B / Chemical effects at metal/oxide interfaces studied by X-ray-absorption spectroscopy by Regan (2001)
  36. 10.1111/j.1460-9568.2009.06701.x / Eur. J. Neurosci. / Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease by Rival (2009)
  37. 10.1016/S0891-5849(00)00494-9 / Free Radic. Biol. Med. / Redox-active iron mediates amyloid-beta toxicity by Rottkamp (2001)
  38. 10.1097/00005072-199409000-00003 / J. Neuropathol. Exp. Neurol. / Alzheimer's disease: a central role for amyloid by Selkoe (1994)
  39. 10.1177/14.10.725 / J. Histochem. Cytochem. / A Congo red staining method for epoxy-embedded amyloid by Shirahama (1966)
  40. 10.1073/pnas.94.18.9866 / Proc. Natl. Acad. Sci. USA / Iron accumulation in Alzheimer disease is a source of redox-generated free radicals by Smith (1997)
  41. 10.1063/1.3249578 / App Phys. Lett. / Remediation of Cr(VI) by biogenic magnetic nanoparticles: an X-ray magnetic circular dichroism study by Telling (2009)
  42. 10.1038/ngeo433 / Nat. Geosci. / Preservation of iron(II) by carbon-rich matrices in a hydrothermal plume by Tone (2009)
  43. 10.1088/0953-8984/4/16/019 / J. Phys. Condens. Matter / The 2p absorption-spectra of 3d transition-metal compounds in tetrahedral and octahedral symmetry by van der Laan (1992)
  44. 10.1088/1742-6596/430/1/012127 / J. Phys. Conf. Ser. / Applications of soft X-ray magnetic dichroism by van der Laan (2013)
  45. 10.1016/j.ccr.2014.03.018 / Coord. Chem. Rev. / X-ray magnetic circular dichroism - a versatile tool to study magnetism by van der Laan (2014)
  46. 10.1016/j.freeradbiomed.2010.10.707 / Free Radic. Biol. Med. / Beta-amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease by Wan (2011)
  47. 10.1016/j.archger.2014.04.002 / Arch. Gerontol. Geriatr. / Age-related iron deposition in the basal ganglia of controls and Alzheimer disease patients quantified using susceptibility weighted imaging by Wang (2014)
  48. 10.1074/jbc.R800018200 / J. Biol. Chem. / Amyloid β-protein toxicity and the pathogenesis of Alzheimer disease by Yanker (2009)
  49. 10.1016/j.elspec.2014.12.005 / J. Electron Spectrosc. / What is the correct Fe L-23 X-ray absorption spectrum of magnetite? by Zhu (2015)
Dates
Type When
Created 7 years, 11 months ago (Sept. 7, 2017, 2:05 p.m.)
Deposited 3 years, 1 month ago (July 23, 2022, 4:47 p.m.)
Indexed 4 days, 14 hours ago (Aug. 19, 2025, 6:25 a.m.)
Issued 7 years, 10 months ago (Oct. 1, 2017)
Published 7 years, 10 months ago (Oct. 1, 2017)
Published Print 7 years, 10 months ago (Oct. 1, 2017)
Funders 10
  1. Canada Foundation for Innovation 10.13039/501100000196

    Region: Americas

    pri (Trusts, charities, foundations (both public and private))

    Labels2
    1. Fondation canadienne pour l’innovation
    2. CFI
  2. Natural Sciences and Engineering Research Council of Canada 10.13039/501100000038

    Region: Americas

    gov (National government)

    Labels3
    1. Conseil de Recherches en Sciences Naturelles et en Génie du Canada
    2. NSERC
    3. CRSNG
  3. National Research Council Canada 10.13039/501100000046

    Region: Americas

    gov (National government)

    Labels3
    1. Conseil national de recherches Canada
    2. NRC
    3. CNRC
  4. Canadian Institutes of Health Research 10.13039/501100000024

    Region: Americas

    gov (National government)

    Labels6
    1. Instituts de Recherche en Santé du Canada
    2. Canadian Institutes of Health Research (CIHR)
    3. CIHR_IRSC
    4. Canadian Institutes of Health Research | Ottawa ON
    5. CIHR
    6. IRSC
  5. Government of Saskatchewan
  6. Western Economic Diversification Canada 10.13039/501100000045

    Region: Americas

    gov (National government)

    Labels3
    1. Diversification de l'économie de l'Ouest Canada
    2. WD
    3. DEO
  7. University of Saskatchewan 10.13039/100008920

    Region: Americas

    gov (Universities (academic only))

    Labels4
    1. uSask
    2. U of S
    3. U of Saskatchewan
    4. UOS
  8. Health Research Board Ireland and Science Foundation Ireland
  9. Diamond Light Source Ltd
  10. EPSRC 10.13039/501100000266 Engineering and Physical Sciences Research Council

    Region: Europe

    gov (National government)

    Labels4
    1. UKRI Engineering and Physical Sciences Research Council
    2. Engineering and Physical Sciences Research Council - UKRI
    3. Engineering & Physical Sciences Research Council
    4. EPSRC
    Awards4
    1. EP/K035193/1
    2. EP/D066654/1
    3. EP/P503981
    4. EP/K00252X/1

@article{Telling_2017, title={Iron Biochemistry is Correlated with Amyloid Plaque Morphology in an Established Mouse Model of Alzheimer’s Disease}, volume={24}, ISSN={2451-9456}, url={http://dx.doi.org/10.1016/j.chembiol.2017.07.014}, DOI={10.1016/j.chembiol.2017.07.014}, number={10}, journal={Cell Chemical Biology}, publisher={Elsevier BV}, author={Telling, Neil D. and Everett, James and Collingwood, Joanna F. and Dobson, Jon and van der Laan, Gerrit and Gallagher, Joseph J. and Wang, Jian and Hitchcock, Adam P.}, year={2017}, month=oct, pages={1205-1215.e3} }